TRONARTO Trademark

Trademark Overview

On Wednesday, August 17, 2022, a trademark application was filed for TRONARTO with the United States Patent and Trademark Office. The USPTO has given the TRONARTO trademark a serial number of 79350817. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The TRONARTO trademark is filed in the Education & Entertainment Services category with the following description:

Publication of printed matter and publishing of electronic publications with the results of clinical studies involving pharmaceutical preparations
tronarto

General Information

Serial Number79350817
Word MarkTRONARTO
Filing DateWednesday, August 17, 2022
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7256768
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements

Goods and ServicesPublication of printed matter and publishing of electronic publications with the results of clinical studies involving pharmaceutical preparations

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, September 26, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 4, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-PRINCIPAL REGISTER
Monday, November 6, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, August 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023REFUSAL PROCESSED BY IB
Monday, February 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 27, 2023REFUSAL PROCESSED BY MPU
Friday, January 20, 2023ASSIGNED TO EXAMINER
Saturday, December 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 30, 2022NON-FINAL ACTION WRITTEN
Friday, December 30, 2022ASSIGNED TO EXAMINER
Friday, September 30, 2022APPLICATION FILING RECEIPT MAILED
Monday, September 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 23, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

tronarto studies clinical involving pharmaceutical preparations results publications printed matter publishing